Nve's biggest risks in the FY2025 10-K
- Single-source semiconductor wafer suppliers and specialized chemicals drive supply chain vulnerability.
- Medical device integration creates severe product liability and recall risks.
- Customer concentration, specifically Abbott Laboratories, poses revenue loss risk upon agreement expiration.
The risks most specific to Nve
- Risks Related to Our Business
The loss of supply from any of our key single-source wafer suppliers could substantially impact our ability to produce and deliver products and seriously harm our business and financial condition
We lack alternate suppliers for many critical raw silicon and semiconductor foundry wafers obtained from single sources.
- Risks Related to Our Business
Shortages of any critical chemicals or supplies could impact our ability to produce and deliver products and cause loss of revenue
We depend on single sources for critical chemicals, gases, photoresists, polymers, metals, and specialized alloys subject to potential shortages.
- Risks Related to Our Business
A loss of supply from any of our packaging vendors could impact our ability to deliver products and cause loss of revenue
Packaging our products is challenging due to unique materials, magnetic requirements, and high isolation voltage specifications.
- Risks Related to Our Business
We may lose revenue if we are unable to renew customer agreements
Our Supplier Partnering Agreement with Abbott Laboratories expires on December 31, 2025.
- Risks Related to Our Business
Some of our products are incorporated into medical devices, which could expose us to a risk of product liability claims and such claims could seriously harm our business and financial condition
Our incorporation into life-sustaining medical devices, cardiac pacemakers, and ICDs exposes us to product liability claims.
- Risks Related to Our Business
The malfunction of our products in medical devices could lead to the need to recall devices incorporating our products from the market, which may be harmful to our reputation and cause a significant loss of revenue
Product malfunctions could lead to medical device recalls, harming our reputation and causing significant revenue loss.
- Risks Related to Our Business
We may lose business and revenue if our critical production equipment fails
Our production relies on customized or obsolete equipment for defining, depositing, and modifying magnetic properties of thin films.
- Risks Related to Our Business
We could incur losses on our marketable securities
We held $39,996,216 in marketable securities, representing 62% of our total assets, which are subject to bond-market and interest rate risks.
All 22 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business
- 01The loss of supply from any of our key single-source wafer suppliers could substantially impact our ability to produce and deliver products and seriously harm our business and financial condition
- 02Shortages of any critical chemicals or supplies could impact our ability to produce and deliver products and cause loss of revenue
- 03A loss of supply from any of our packaging vendors could impact our ability to deliver products and cause loss of revenue
- 04We risk losing business to our competitors
- 05Failure to meet stringent customer requirements could result in the loss of key customers and reduce our sales
- 06We may lose revenue if we are unable to renew customer agreements
- 07Changes in tax law, in our tax rates, or in exposure to additional income tax liabilities may materially and adversely affect our financial condition, results of operations, and cash flows
- 08Some of our products are incorporated into medical devices, which could expose us to a risk of product liability claims and such claims could seriously harm our business and financial condition
- 09We may lose revenue if we are unable to maintain important certifications
- 10Federal legislation may not protect us against liability for the use of our products in medical devices and a successful liability claim could seriously harm our business and financial condition
- 11The malfunction of our products in medical devices could lead to the need to recall devices incorporating our products from the market, which may be harmful to our reputation and cause a significant loss of revenue
- 12We may lose business and revenue if our critical production equipment fails
- 13We are subject to risks inherent in doing business in foreign countries that could impair our results of operations
- 14Public health crises could have an adverse effect on our operations and financial results
- 15Our business could be negatively impacted by cybersecurity events or information technology disruptions
- 16We face the risk of credit losses
- 17We could incur losses on our marketable securities
- 18We may not be able to enforce our intellectual property rights
Risks Related to Our Industry
- 19We face an uncertain economic environment in the industries we serve, which could adversely affect our business
- 20Our business and our reliance on intellectual property exposes us to litigation risks
Risks Related to Our Stock
- 21Any decisions to reduce or discontinue paying cash dividends to our shareholders could cause the market price of our common stock to decline
- 22The price of our common stock may be adversely affected by significant price fluctuations due to a number of factors, many of which are beyond our control
Other Nve 10-Ks
- FY2026 10-K risk factors23 risks1 new7 reworded
Paid family and medical leave in Minnesota increased employment costs and may increase employee absences starting January 1, 2026.
Filed May 06, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.